Normal view MARC view ISBD view

Mucosal gene expression changes induced by anti-TNF treatment in inflammatory bowel disease patients. [electronic resource]

By:

Milanesi, Elena

Contributor(s):

Producer: 20200317Description: 831-836 p. digitalISSN:

1098-2299

Subject(s):

Online resources:

Available from publisher's website

In: Drug development research vol. 80

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

881 A nanomechanical study of the effects of colistin on the Klebsiella pneumoniae AJ218 capsule.
by Mularski, Anna
882 Capsular Polysaccharide Expression in Commensal Streptococcus Species: Genetic and Antigenic Similarities to Streptococcus pneumoniae.
by Skov Sørensen, Uffe B
883 Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions.
by Bellich, Barbara
884 Perspectives on the current Haemophilus vaccine.
by Daum, R S
885 Three-dimensional structural analysis of the group B polysaccharide of Neisseria meningitidis 6275 by two-dimensional NMR: the polysaccharide is suggested to exist in helical conformations in solution.
by Yamasaki, R
886 Isolation and characterization of bacteriophages specific for capsular antigens K3, K7, K12, and K13 of Escherichia coli.
by Nimmich, W
887 Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
by Nomura, S
888 Biosynthesis of dermatan sulphate. Defructosylated Escherichia coli K4 capsular polysaccharide as a substrate for the D-glucuronyl C-5 epimerase, and an indication of a two-base reaction mechanism.
by Hannesson, H H
889 Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants.
by Schmitt, H J
890 Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.
by Kauppi-Korkeila, M
891 Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae.
by Seong, S Y
892 Hib vaccination controversy and the declaration of commercial interest.
by Taneja, Vikas
893 The determination of phosphorus in Haemophilus influenzae type b conjugate vaccines by inductively coupled plasma-atomic emission spectrometry.
by Swartz, L A
894 [Noncapsular mutants of Vibrio cholerae serogroup O139: their isolation, identification and use for the preparation of an O139 diagnostic antiserum].
by Chekhovskaia, G V
895 Periodate-sensitive immunological cross-reactivity between keyhole limpet haemocyanin (KLH) and serodiagnostic Schistosoma mansoni egg antigens.
by Hamilton, J V
896 Enhanced biofilm formation and loss of capsule synthesis: deletion of a putative glycosyltransferase in Porphyromonas gingivalis.
by Davey, Mary E
897 Mycobacterial survival strategies in the phagosome: defence against host stresses.
by Ehrt, Sabine
898 Determination of capsulation status in Haemophilus influenzae by multiplex polymerase chain reaction.
by Nelson, Kevin Lee
899 Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
by Hajjeh, R A
900 Characterization of the structure and biological functions of a capsular polysaccharide produced by Staphylococcus saprophyticus.
by Park, Sunny